bionomics-rgb-1024px.png
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting
December 03, 2024 16:05 ET | Bionomics Ltd
ADELAIDE, Australia and CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel,...
X4-logo.png
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2024 16:05 ET | X4 Pharmaceuticals
BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective...
NeuroPace Logo.png
NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome
December 03, 2024 16:05 ET | NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
latham pool logo.png
Latham Group, Inc. to Participate in the Wolfe December Conference
December 03, 2024 16:05 ET | Latham Pool Products
LATHAM, N.Y., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Latham Group, Inc., the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New...
aec.jpg
Anfield Energy Inc. Announces Shareholder Approval of Plan of Arrangement
December 03, 2024 16:03 ET | Anfield Energy Inc.
VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that the proposed...
IREN_RGB_LOGO_colour_green.jpg
IREN announces proposed convertible notes offering
December 03, 2024 16:01 ET | IREN
SYDNEY, Dec. 03, 2024 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (ACN 629 842 799) (“IREN”) today announced its intention to offer, subject to market and other conditions, $300 million...
Tectonic-Logo-full-color.png
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
December 03, 2024 16:01 ET | Tectonic Therapeutic
WATERTOWN, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”) a clinical stage biotechnology company focused on the discovery and development of...
Intellia.jpg
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 03, 2024 16:01 ET | Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based...
MPY LOGO (002).PNG
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
December 03, 2024 16:01 ET | Mulvihill Premium Yield
TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly cash distribution for its ETF Class in the amount of $0.06400 per unit, payable on January...
Premium Global logo.jpg
Premium Global Income Split Corp. Declares Monthly Distribution
December 03, 2024 16:01 ET | Premium Global Income Split Corp.
TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- (TSX: PGIC; PGIC.PR.A) Premium Global Income Split Corp. has declared monthly distributions payable on December 31, 2024 to shareholders of record on...